IP Library › Granted Patent US 12,589,180
Granted Patent B2
US 12,589,180 · App. 18/628,279 · Granted Mar 31, 2026

Medical device having a polymeric nanocomposite actively controlled for rapid healing of fractures and soft tissue injury

Inventor: Raghavendra Vitthalrao Ghuge (Tyler, TX)
Assignee: SLEEP SOLUTIONS OF TEXAS, LLC
A61L15/14A61L15/10A61L15/12A61L2400/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,589,180
App. No.
18/628,279
Granted
Mar 31, 2026
Kind
B2
Abstract

Medical devices having a controller in operative communication with a polymeric nanocomposite treatment device are disclosed. The polymeric nanocomposite treatment device includes a layered construction having a top layer and a bottom layer, which both include a matrix variable density polytetrafluoroethylene, a layer of carbon nanostructures juxtaposed to one each of the top layer and the bottom layer, and an electronic network layer between the two layers of carbon nanostructures. The electronic network layer includes a quantum micro-chiplet (QMC) or an octagonal quantum micro-chiplet integrated with a photonic integrated circuit.

Claims (16)

1 . A medical device comprising:

a controller in operative communication with a polymeric nanocomposite treatment device, the polymeric nanocomposite treatment device comprising:

a layered construction having a top layer and a bottom layer both comprising a matrix variable density polytetrafluoroethylene, a layer of carbon nanostructures juxtaposed to one each of the top layer and the bottom layer, and an electronic network layer between the top layer and the bottom layer,

wherein the electronic network layer comprises a quantum micro-chiplet QMC or an octagonal quantum micro-chiplet integrated with a photonic integrated circuit.

2 . The medical device of claim 1 , further comprising a tether operatively connecting the controller to the polymeric nanocomposite treatment site device.

3 . The medical device of claim 2 wherein the controller is mateable to a first end of the tether and is lockable thereto by a primary lock comprising an expandable male member of either the controller or the tether and a secondary lock configured to opened before the primary lock can be opened.

4 . The medical device of claim 3 , wherein the expandable male member comprises a compression spring in compression between radially opposing drivers, and the radially opposing drivers are in operative mechanical communication with a security nut, wherein rotation of the security nut activates opposing rods to push the radially opposing drivers toward one another, thereby compressing the compression spring and reducing the size of the expandable male member to render it removable from either the controller or the tether.

5 . The medical device of claim 2 , wherein the tether comprises carbon nanostructures configured for electrical and/or thermal communication between the controller and the polymeric nanocomposite treatment device.

6 . The medical device of claim 2 , wherein the tether comprises electrical connections and conduits configured for operative communication between the controller and the polymeric nanocomposite treatment device.

7 . The medical device of claim 1 , wherein the electronic network layer further comprises a power source in electrical communication with the quantum micro-chiplet and the photonic integrated circuit.

8 . The medical device of claim 7 , wherein the electronic network layer comprises one or more of a sensor module, an electromagnetic field module, robotics module, an intravascular ultrasound module, and a vacuum module.

9 . The medical device of claim 8 , wherein the sensor modules comprise one or more of a capacitive micromachined ultrasonic transducer (CMUT), a complementary metal-oxide-semiconductor (CMOS) based sensor, an infrared sensor, a fiberoptic sensor, a radioisotope sensor, a temperature sensor, and a pressure sensor.

10 . The medical device of claim 1 , wherein the layered construction of the polymeric nanocomposite treatment device further comprises one or more of a sensor module, an electromagnetic field module, robotics module, an intravascular ultrasound module, and a vacuum module as a discrete layer interleaved by juxtaposed layers of carbon nanostructures positioned above or below the electronic network layer.

11 . The medical device of claim 10 , wherein each discrete layer is in operative communication with the electronic network layer.

12 . The medical device of claim 1 , further comprising a treatment site covering configured to hold the polymeric nanocomposite treatment device against a treatment site of a user.

13 . The medical device of claim 12 , wherein the treatment site covering is selected from the group consisting of a wrap, a band, a brace, a cast, and a bandage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2024
From: GHUGE, RAGHAVENDRA VITTHALRAO
To: SLEEP SOLUTIONS OF TEXAS, LLC
Reel/Frame 067387/0987 →
Continuity (2)
Provisional Application 63494799 · Apr 7, 2023
Related Publication 20240335583A1 · Oct 10, 2024
References Cited (7)
Tuan et al. “Development of a System for Real-Time Monitoring of Pressure, Temperature, and Humidity in Casts,” Sensors 2019, 19(10), 2417. May 27, 2019 (May 27, 2019). Retrieved on Jul. 2, 2024. Retrieved trom entire d… [cited by examiner]
Bex et al., Growth hormone and bone health, Pubmed, 2003, 60 Suppl 3:80-6. doi: 10.1159/000074507. [cited by applicant]
Trippel, Potential role of insulinlike growth factors infracture healing, Clinical Orthopaedics and Related Research, Oct. 1998, pp. S301-S313, vol. 355. [cited by applicant]
Syed et al., Pulsed electromagnetic fields for the treatment of bone fractures, Bangladesh Med Res Counc Bull, Apr. 1999, pp. 6-10, vol. 25 issue 1. [cited by applicant]
Anthem BlueCross, Clinical UM Guideline Ultrasound Bone Growth Stimulation, Jul. 6, 2022, 12 pages. [cited by applicant]
International Search Report and Written Opinion, Application No. PCT/US2024/023178, Jul. 15, 2024, 8 pages. [cited by applicant]
International Search Report and Written Opinion, Application No. PCT/US2024/023209 Jul. 10, 2024, 7 pages. [cited by applicant]